Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Cellebrite DI (CLBT) Current Assets (2020 - 2025)

Cellebrite DI (CLBT) has 6 years of Current Assets data on record, last reported at $575.8 million in Q4 2025.

  • For Q4 2025, Current Assets rose 1.45% year-over-year to $575.8 million; the TTM value through Dec 2025 reached $1.1 billion, up 94.66%, while the annual FY2025 figure was $575.8 million, 1.45% up from the prior year.
  • Current Assets reached $575.8 million in Q4 2025 per CLBT's latest filing, up from $567.6 million in the prior quarter.
  • Across five years, Current Assets topped out at $575.8 million in Q4 2025 and bottomed at $273.2 million in Q4 2021.
  • Average Current Assets over 5 years is $426.9 million, with a median of $422.1 million recorded in 2023.
  • Peak YoY movement for Current Assets: surged 781.04% in 2021, then grew 1.45% in 2025.
  • A 5-year view of Current Assets shows it stood at $273.2 million in 2021, then grew by 8.32% to $295.9 million in 2022, then soared by 42.63% to $422.1 million in 2023, then soared by 34.47% to $567.6 million in 2024, then increased by 1.45% to $575.8 million in 2025.
  • Per Business Quant database, its latest 3 readings for Current Assets were $575.8 million in Q4 2025, $567.6 million in Q4 2024, and $422.1 million in Q4 2023.